# FDA Inspection 1160304 - Octapharma Plasma Inc - December 16, 2021

Source: https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/ced2cd3d-b33a-4254-a3ba-54c2f5eb0a02
Source feed: FDA_Inspections

> FDA Inspection 1160304 for Octapharma Plasma Inc on December 16, 2021. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1160304
- Company Name: Octapharma Plasma Inc
- Inspection Date: 2021-12-16
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1160304 - 2021-12-16](https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/288a0dda-78ca-40c8-afeb-8365d0af8b5a)

Company: https://www.keypedia.com/companies/octapharma-plasma-inc/91f294c4-c3af-4652-b50f-0f0bb75f07e8

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d